data_1az6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1az6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 CA-C-O 120.221 -0.21 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 N-CA-C 115.304 0.881 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.985 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.84 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.13 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.848 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.748 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 121.954 0.752 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.961 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.973 0 CA-C-O 121.162 0.312 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 CA-C-O 121.38 0.434 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.98 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.775 0 CA-C-O 121.715 0.62 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.849 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 120.261 -0.188 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -123.86 133.57 53.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.671 1.589 . . . . 0.0 113.102 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -77.92 64.13 3.07 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -64.3 96.92 0.17 Allowed 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.163 -0.961 . . . . 0.0 112.327 169.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.46 79.13 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.59 1.556 . . . . 0.0 113.874 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.7 -81.43 0.66 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.738 1.637 . . . . 0.0 113.543 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -103.12 -57.46 2.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.269 1.428 . . . . 0.0 112.944 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -91.35 72.74 6.13 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.757 1.223 . . . . 0.0 112.962 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -61.82 137.28 58.23 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.2 165.85 23.99 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.768 1.627 . . . . 0.0 114.402 173.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.2 -58.91 11.18 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -150.69 178.76 8.79 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.071 1.748 . . . . 0.0 111.601 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 t -44.15 95.1 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.772 1.629 . . . . 0.0 115.104 172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -75.79 -80.19 0.09 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.83 1.252 . . . . 0.0 111.592 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.85 119.13 20.19 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 111.776 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -46.61 -40.8 11.96 Favored Glycine 0 CA--C 1.548 2.102 0 O-C-N 121.009 -1.057 . . . . 0.0 115.304 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -86.65 78.52 9.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.135 1.774 . . . . 0.0 108.05 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -135.96 34.25 2.87 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.116 1.366 . . . . 0.0 111.115 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -76.49 72.62 3.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.763 1.625 . . . . 0.0 113.932 -166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.85 145.33 27.44 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.791 1.636 . . . . 0.0 113.424 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.13 -162.99 53.96 Favored Glycine 0 CA--C 1.546 1.985 0 O-C-N 120.914 -1.116 . . . . 0.0 115.105 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.049 -1.453 . . . . 0.0 113.362 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 165.95 131.0 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 129.372 3.069 . . . . 0.0 109.008 -171.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -106.25 -172.91 2.17 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.951 1.25 . . . . 0.0 112.903 172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -138.43 -169.35 2.58 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.05 1.74 . . . . 0.0 113.624 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.15 75.93 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.43 172.41 36.06 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 128.513 2.959 . . . . 0.0 111.795 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 117.861 -1.066 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -87.02 -138.39 0.09 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.865 1.666 . . . . 0.0 109.326 152.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 t -95.33 179.93 5.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 113.029 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -107.59 -84.16 0.53 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.471 1.508 . . . . 0.0 108.729 162.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -44.64 130.91 6.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.039 1.336 . . . . 0.0 114.165 166.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.06 -171.76 24.9 Favored Glycine 0 CA--C 1.548 2.13 0 C-N-CA 125.705 1.621 . . . . 0.0 115.438 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.04 173.08 11.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.238 2.215 . . . . 0.0 111.157 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -59.75 86.55 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.713 1.205 . . . . 0.0 114.229 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -118.42 -25.82 6.41 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.78 170.29 9.55 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.366 1.466 . . . . 0.0 113.422 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -107.27 0.49 Allowed Glycine 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -57.46 77.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.902 2.137 . . . . 0.0 109.761 145.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -125.02 -74.19 0.62 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 127.388 2.275 . . . . 0.0 108.637 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -52.83 -65.66 0.52 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.451 1.119 . . . . 0.0 112.341 167.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.29 65.41 8.27 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 120.504 -1.372 . . . . 0.0 111.63 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 132.05 2.74 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.534 1.54 . . . . 0.0 113.055 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -113.85 163.73 14.69 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.05 1.74 . . . . 0.0 112.514 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -83.31 42.94 0.85 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.564 1.545 . . . . 0.0 113.905 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -22.99 -54.02 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 118.692 2.849 . . . . 0.0 118.692 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.85 101.11 8.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.836 1.655 . . . . 0.0 112.066 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -47.1 -59.5 5.63 Favored Glycine 0 CA--C 1.542 1.748 0 C-N-CA 125.476 1.513 . . . . 0.0 115.424 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -108.29 -37.7 5.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.193 1.797 . . . . 0.0 112.723 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 p 54.49 43.17 30.74 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.73 129.72 42.39 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.193 1.397 . . . . 0.0 111.637 165.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.19 68.94 0.34 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.176 1.39 . . . . 0.0 114.714 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.52 -71.41 0.2 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.028 1.775 . . . . 0.0 114.837 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -137.56 124.01 20.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.801 1.24 . . . . 0.0 112.053 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.3 m -69.35 -69.02 0.36 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.419 1.088 . . . . 0.0 109.421 162.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.53 103.49 2.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 112.804 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.7 -136.36 0.07 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.595 1.158 . . . . 0.0 113.978 -172.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.31 -129.77 6.4 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.982 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 118.119 -0.943 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -68.82 63.04 0.11 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 123.208 1.48 . . . . 0.0 113.02 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -30.22 70.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.43 2.292 . . . . 0.0 112.171 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -123.33 140.31 53.15 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.395 2.278 . . . . 0.0 109.501 161.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 92.94 3.69 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.82 -172.2 47.3 Favored Glycine 0 CA--C 1.545 1.961 0 C-N-CA 125.64 1.59 . . . . 0.0 115.353 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -109.62 61.74 0.6 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.537 1.535 . . . . 0.0 110.033 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -54.63 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 119.334 3.087 . . . . 0.0 119.334 -148.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -55.12 103.38 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.846 1.259 . . . . 0.0 112.82 163.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.73 59.64 0.88 Allowed 'General case' 0 CA--C 1.554 1.107 0 O-C-N 120.617 -1.302 . . . . 0.0 114.129 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 -78.3 0.06 OUTLIER Glycine 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -171.19 154.92 4.16 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 129.96 3.304 . . . . 0.0 107.756 171.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -121.86 143.42 49.43 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -165.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -101.52 154.3 18.96 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.176 -1.577 . . . . 0.0 112.916 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.56 67.16 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -163.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.77 161.79 20.13 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 128.117 2.77 . . . . 0.0 113.364 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -121.62 -52.57 2.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.891 1.276 . . . . 0.0 113.658 -170.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p 39.91 51.05 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 161.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -94.86 -56.34 2.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.849 1.659 . . . . 0.0 112.148 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.35 94.68 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 O-C-N 120.969 -1.082 . . . . 0.0 112.899 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -39.9 -50.98 3.38 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 117.82 -1.086 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -129.16 -176.9 4.02 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.303 1.441 . . . . 0.0 113.564 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -65.41 178.45 0.94 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.726 2.01 . . . . 0.0 115.442 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -152.88 -89.93 0.05 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.365 1.466 . . . . 0.0 110.596 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.24 143.79 43.22 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 120.907 -1.121 . . . . 0.0 112.576 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.68 -45.32 94.8 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -122.06 169.26 11.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.448 1.499 . . . . 0.0 112.777 -161.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 t -81.26 115.75 20.8 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.682 1.193 . . . . 0.0 111.223 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -91.7 90.35 7.51 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 112.443 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -23.72 82.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 128.852 2.861 . . . . 0.0 115.597 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.69 -170.03 34.46 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 127.532 2.491 . . . . 0.0 110.596 -173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -118.52 -24.35 6.82 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.263 1.825 . . . . 0.0 113.644 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -113.62 142.96 45.35 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 143.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.282 52.3 m80 81.16 61.04 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 127.003 2.121 . . . . 0.0 115.254 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.77 91.22 7.85 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.79 2.836 . . . . 0.0 113.981 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.05 144.59 35.29 Favored Glycine 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -158.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.251 10.9 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.66 103.1 14.99 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 120.994 1.724 . . . . 0.0 112.432 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -58.99 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.951 1.7 . . . . 0.0 111.697 163.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -71.81 136.53 47.09 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 120.376 -1.453 . . . . 0.0 112.54 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 42.26 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.57 -171.24 26.78 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 127.352 2.406 . . . . 0.0 112.564 170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.852 -1.071 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -77.21 54.75 1.12 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 120.722 1.601 . . . . 0.0 113.632 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -112.52 98.85 7.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.196 1.798 . . . . 0.0 109.872 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -146.68 -57.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.906 1.282 . . . . 0.0 112.837 -173.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 117.07 13.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.334 1.054 . . . . 0.0 113.168 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.46 -79.18 0.07 OUTLIER Glycine 0 CA--C 1.546 1.98 0 C-N-CA 125.373 1.463 . . . . 0.0 116.752 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.87 90.19 3.49 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.533 1.133 . . . . 0.0 110.521 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -56.56 2.39 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.522 0.729 . . . . 0.0 111.85 170.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -45.47 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.12 2.168 . . . . 0.0 114.569 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.81 -150.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -167.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.53 -137.95 3.34 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 124.826 1.203 . . . . 0.0 113.254 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 117.93 -1.033 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -132.6 62.19 1.65 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.75 1.62 . . . . 0.0 110.099 166.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -95.79 124.74 39.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.624 1.569 . . . . 0.0 111.332 -177.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -71.14 164.35 25.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.082 1.353 . . . . 0.0 114.264 -174.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.7 67.63 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.867 1.667 . . . . 0.0 115.188 -173.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.31 143.79 16.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.717 2.103 . . . . 0.0 114.636 -176.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.18 175.16 7.8 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 118.648 0.658 . . . . 0.0 110.335 152.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 51.21 0.97 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.428 1.091 . . . . 0.0 112.91 173.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.39 103.17 12.55 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.19 0.996 . . . . 0.0 110.861 172.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.15 161.2 30.87 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.61 -82.41 1.42 Allowed Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.958 -1.089 . . . . 0.0 113.16 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 CA-C-O 120.221 -0.21 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 N-CA-C 115.304 0.881 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.985 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.84 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.13 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 36' ' ' LEU . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' C ' HG21 ' A' ' 23' ' ' THR . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.848 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.748 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 121.954 0.752 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.961 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.973 0 CA-C-O 121.162 0.312 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.477 HG21 ' SG ' ' A' ' 35' ' ' CYS . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 23' ' ' THR . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HG23 ' A' ' 23' ' ' THR . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' H ' HG22 ' A' ' 18' ' ' VAL 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 CA-C-O 121.38 0.434 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.98 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.775 0 CA-C-O 121.715 0.62 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.409 HG23 ' SG ' ' A' ' 35' ' ' CYS . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 23' ' ' THR . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.849 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 120.261 -0.188 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -123.86 133.57 53.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.671 1.589 . . . . 0.0 113.102 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -77.92 64.13 3.07 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -64.3 96.92 0.17 Allowed 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.163 -0.961 . . . . 0.0 112.327 169.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.46 79.13 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.59 1.556 . . . . 0.0 113.874 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.7 -81.43 0.66 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.738 1.637 . . . . 0.0 113.543 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -103.12 -57.46 2.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.269 1.428 . . . . 0.0 112.944 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -91.35 72.74 6.13 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.757 1.223 . . . . 0.0 112.962 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -61.82 137.28 58.23 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.2 165.85 23.99 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.768 1.627 . . . . 0.0 114.402 173.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.2 -58.91 11.18 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -150.69 178.76 8.79 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.071 1.748 . . . . 0.0 111.601 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 t -44.15 95.1 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.772 1.629 . . . . 0.0 115.104 172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -75.79 -80.19 0.09 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.83 1.252 . . . . 0.0 111.592 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.85 119.13 20.19 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 111.776 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -46.61 -40.8 11.96 Favored Glycine 0 CA--C 1.548 2.102 0 O-C-N 121.009 -1.057 . . . . 0.0 115.304 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -86.65 78.52 9.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.135 1.774 . . . . 0.0 108.05 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -135.96 34.25 2.87 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.116 1.366 . . . . 0.0 111.115 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -76.49 72.62 3.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.763 1.625 . . . . 0.0 113.932 -166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.85 145.33 27.44 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.791 1.636 . . . . 0.0 113.424 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.13 -162.99 53.96 Favored Glycine 0 CA--C 1.546 1.985 0 O-C-N 120.914 -1.116 . . . . 0.0 115.105 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.049 -1.453 . . . . 0.0 113.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 165.95 131.0 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 129.372 3.069 . . . . 0.0 109.008 -171.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -106.25 -172.91 2.17 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.951 1.25 . . . . 0.0 112.903 172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -138.43 -169.35 2.58 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.05 1.74 . . . . 0.0 113.624 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.15 75.93 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.43 172.41 36.06 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 128.513 2.959 . . . . 0.0 111.795 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 117.861 -1.066 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -87.02 -138.39 0.09 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.865 1.666 . . . . 0.0 109.326 152.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 t -95.33 179.93 5.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 113.029 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -107.59 -84.16 0.53 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.471 1.508 . . . . 0.0 108.729 162.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -44.64 130.91 6.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.039 1.336 . . . . 0.0 114.165 166.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.06 -171.76 24.9 Favored Glycine 0 CA--C 1.548 2.13 0 C-N-CA 125.705 1.621 . . . . 0.0 115.438 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 36' ' ' LEU . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' C ' HG21 ' A' ' 23' ' ' THR . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.04 173.08 11.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.238 2.215 . . . . 0.0 111.157 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -59.75 86.55 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.713 1.205 . . . . 0.0 114.229 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -118.42 -25.82 6.41 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.78 170.29 9.55 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.366 1.466 . . . . 0.0 113.422 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -107.27 0.49 Allowed Glycine 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -57.46 77.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.902 2.137 . . . . 0.0 109.761 145.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -125.02 -74.19 0.62 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 127.388 2.275 . . . . 0.0 108.637 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -52.83 -65.66 0.52 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.451 1.119 . . . . 0.0 112.341 167.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.29 65.41 8.27 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 120.504 -1.372 . . . . 0.0 111.63 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 132.05 2.74 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.534 1.54 . . . . 0.0 113.055 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -113.85 163.73 14.69 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.05 1.74 . . . . 0.0 112.514 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -83.31 42.94 0.85 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.564 1.545 . . . . 0.0 113.905 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -22.99 -54.02 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 118.692 2.849 . . . . 0.0 118.692 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.85 101.11 8.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.836 1.655 . . . . 0.0 112.066 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -47.1 -59.5 5.63 Favored Glycine 0 CA--C 1.542 1.748 0 C-N-CA 125.476 1.513 . . . . 0.0 115.424 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -108.29 -37.7 5.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.193 1.797 . . . . 0.0 112.723 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 p 54.49 43.17 30.74 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.73 129.72 42.39 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.193 1.397 . . . . 0.0 111.637 165.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.19 68.94 0.34 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.176 1.39 . . . . 0.0 114.714 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.52 -71.41 0.2 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.028 1.775 . . . . 0.0 114.837 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -137.56 124.01 20.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.801 1.24 . . . . 0.0 112.053 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.3 m -69.35 -69.02 0.36 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.419 1.088 . . . . 0.0 109.421 162.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.53 103.49 2.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 112.804 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.7 -136.36 0.07 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.595 1.158 . . . . 0.0 113.978 -172.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.31 -129.77 6.4 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.982 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 118.119 -0.943 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -68.82 63.04 0.11 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 123.208 1.48 . . . . 0.0 113.02 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -30.22 70.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.43 2.292 . . . . 0.0 112.171 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -123.33 140.31 53.15 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.395 2.278 . . . . 0.0 109.501 161.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 92.94 3.69 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.82 -172.2 47.3 Favored Glycine 0 CA--C 1.545 1.961 0 C-N-CA 125.64 1.59 . . . . 0.0 115.353 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -109.62 61.74 0.6 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.537 1.535 . . . . 0.0 110.033 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -54.63 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 119.334 3.087 . . . . 0.0 119.334 -148.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -55.12 103.38 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.846 1.259 . . . . 0.0 112.82 163.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.73 59.64 0.88 Allowed 'General case' 0 CA--C 1.554 1.107 0 O-C-N 120.617 -1.302 . . . . 0.0 114.129 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 -78.3 0.06 OUTLIER Glycine 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -171.19 154.92 4.16 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 129.96 3.304 . . . . 0.0 107.756 171.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -121.86 143.42 49.43 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -165.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -101.52 154.3 18.96 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.176 -1.577 . . . . 0.0 112.916 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.56 67.16 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -163.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.77 161.79 20.13 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 128.117 2.77 . . . . 0.0 113.364 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.477 HG21 ' SG ' ' A' ' 35' ' ' CYS . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 23' ' ' THR . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HG23 ' A' ' 23' ' ' THR . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -121.62 -52.57 2.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.891 1.276 . . . . 0.0 113.658 -170.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p 39.91 51.05 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 161.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -94.86 -56.34 2.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.849 1.659 . . . . 0.0 112.148 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.35 94.68 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 O-C-N 120.969 -1.082 . . . . 0.0 112.899 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -39.9 -50.98 3.38 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 117.82 -1.086 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -129.16 -176.9 4.02 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.303 1.441 . . . . 0.0 113.564 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -65.41 178.45 0.94 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.726 2.01 . . . . 0.0 115.442 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -152.88 -89.93 0.05 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.365 1.466 . . . . 0.0 110.596 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.24 143.79 43.22 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 120.907 -1.121 . . . . 0.0 112.576 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.68 -45.32 94.8 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' H ' HG22 ' A' ' 18' ' ' VAL 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -122.06 169.26 11.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.448 1.499 . . . . 0.0 112.777 -161.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 t -81.26 115.75 20.8 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.682 1.193 . . . . 0.0 111.223 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -91.7 90.35 7.51 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 112.443 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -23.72 82.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 128.852 2.861 . . . . 0.0 115.597 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.69 -170.03 34.46 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 127.532 2.491 . . . . 0.0 110.596 -173.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -118.52 -24.35 6.82 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.263 1.825 . . . . 0.0 113.644 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -113.62 142.96 45.35 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 143.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.282 52.3 m80 81.16 61.04 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 127.003 2.121 . . . . 0.0 115.254 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.77 91.22 7.85 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.79 2.836 . . . . 0.0 113.981 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.05 144.59 35.29 Favored Glycine 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -158.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.251 10.9 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.66 103.1 14.99 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 120.994 1.724 . . . . 0.0 112.432 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -58.99 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.951 1.7 . . . . 0.0 111.697 163.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -71.81 136.53 47.09 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 120.376 -1.453 . . . . 0.0 112.54 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 42.26 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.57 -171.24 26.78 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 127.352 2.406 . . . . 0.0 112.564 170.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.852 -1.071 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.21 54.75 1.12 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 120.722 1.601 . . . . 0.0 113.632 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -112.52 98.85 7.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.196 1.798 . . . . 0.0 109.872 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -146.68 -57.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.906 1.282 . . . . 0.0 112.837 -173.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 117.07 13.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.334 1.054 . . . . 0.0 113.168 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.46 -79.18 0.07 OUTLIER Glycine 0 CA--C 1.546 1.98 0 C-N-CA 125.373 1.463 . . . . 0.0 116.752 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.87 90.19 3.49 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.533 1.133 . . . . 0.0 110.521 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -56.56 2.39 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.522 0.729 . . . . 0.0 111.85 170.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -45.47 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.12 2.168 . . . . 0.0 114.569 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.81 -150.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -167.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.53 -137.95 3.34 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 124.826 1.203 . . . . 0.0 113.254 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.409 HG23 ' SG ' ' A' ' 35' ' ' CYS . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 23' ' ' THR . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 117.93 -1.033 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -132.6 62.19 1.65 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.75 1.62 . . . . 0.0 110.099 166.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -95.79 124.74 39.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.624 1.569 . . . . 0.0 111.332 -177.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -71.14 164.35 25.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.082 1.353 . . . . 0.0 114.264 -174.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.7 67.63 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.867 1.667 . . . . 0.0 115.188 -173.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.31 143.79 16.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.717 2.103 . . . . 0.0 114.636 -176.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.18 175.16 7.8 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 118.648 0.658 . . . . 0.0 110.335 152.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 51.21 0.97 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.428 1.091 . . . . 0.0 112.91 173.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.39 103.17 12.55 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.19 0.996 . . . . 0.0 110.861 172.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.15 161.2 30.87 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.61 -82.41 1.42 Allowed Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.958 -1.089 . . . . 0.0 113.16 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.503 0 CA-C-O 120.221 -0.21 . . . . 0.0 113.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 N-CA-C 115.304 0.881 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.985 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.84 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.13 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 36' ' ' LEU . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' C ' HG21 ' A' ' 23' ' ' THR . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.848 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.748 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.742 0 CA-C-O 121.954 0.752 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.961 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.973 0 CA-C-O 121.162 0.312 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.477 HG21 ' SG ' ' A' ' 35' ' ' CYS . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 23' ' ' THR . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HG23 ' A' ' 23' ' ' THR . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' H ' HG22 ' A' ' 18' ' ' VAL 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 CA-C-O 121.38 0.434 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.98 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.775 0 CA-C-O 121.715 0.62 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.409 HG23 ' SG ' ' A' ' 35' ' ' CYS . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 23' ' ' THR . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.849 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 120.261 -0.188 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -123.86 133.57 53.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.671 1.589 . . . . 0.0 113.102 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.8 p -77.92 64.13 3.07 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -64.3 96.92 0.17 Allowed 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.163 -0.961 . . . . 0.0 112.327 169.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.46 79.13 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.59 1.556 . . . . 0.0 113.874 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.7 -81.43 0.66 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 125.738 1.637 . . . . 0.0 113.543 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -72.09 81.65 0.96 Allowed 'General case' 0 CA--C 1.554 1.104 0 O-C-N 120.469 -1.606 . . . . 0.0 113.985 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.8 p -54.87 -42.55 72.2 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.978 0.911 . . . . 0.0 113.172 166.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 -110.1 0.61 Allowed Glycine 0 CA--C 1.545 1.914 0 C-N-CA 124.528 1.061 . . . . 0.0 115.221 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.41 103.23 1.48 Allowed Glycine 0 CA--C 1.541 1.693 0 C-N-CA 124.42 1.009 . . . . 0.0 111.475 -163.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.56 117.38 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 O-C-N 120.779 -1.424 . . . . 0.0 112.832 -166.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.22 14.55 24.0 Favored Glycine 0 CA--C 1.55 2.253 0 C-N-CA 125.013 1.292 . . . . 0.0 114.232 -157.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -54.06 119.16 4.69 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.669 2.388 . . . . 0.0 115.215 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m -73.06 45.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.124 -1.61 . . . . 0.0 113.512 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.46 178.64 39.25 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 116.819 1.488 . . . . 0.0 116.819 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -69.07 118.76 5.88 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 124.54 3.493 . . . . 0.0 114.34 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -65.52 -7.34 14.02 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -169.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -100.02 108.66 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 119.74 -1.85 . . . . 0.0 115.018 -163.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.6 -158.43 0.05 OUTLIER 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 -53.87 2.56 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.162 2.585 . . . . 0.0 114.647 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -177.83 -164.71 0.09 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 128.183 2.593 . . . . 0.0 111.912 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.15 -116.06 4.66 Favored Glycine 0 CA--C 1.542 1.753 0 C-N-CA 127.339 2.399 . . . . 0.0 109.461 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -126.3 -50.24 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.948 1.374 . . . . 0.0 112.818 162.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -140.48 165.99 25.94 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -95.13 78.35 3.52 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.345 1.458 . . . . 0.0 109.275 161.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.72 136.06 33.11 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.465 1.506 . . . . 0.0 114.541 -156.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.26 130.64 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.36 -73.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.077 1.351 . . . . 0.0 109.779 163.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -104.43 155.28 37.55 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.565 1.546 . . . . 0.0 109.258 154.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -44.72 -43.35 14.73 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.801 3.001 . . . . 0.0 115.051 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -80.22 -0.56 36.81 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -130.93 102.66 6.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.657 1.983 . . . . 0.0 111.4 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -109.74 130.8 55.48 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.348 1.459 . . . . 0.0 112.705 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -121.68 149.6 42.98 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.663 2.385 . . . . 0.0 113.703 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.7 t -73.64 80.57 1.51 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.684 1.593 . . . . 0.0 112.785 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.904 2.482 . . . . 0.0 111.093 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -103.12 -57.46 2.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.269 1.428 . . . . 0.0 112.944 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -91.35 72.74 6.13 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.757 1.223 . . . . 0.0 112.962 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -61.82 137.28 58.23 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.2 165.85 23.99 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.768 1.627 . . . . 0.0 114.402 173.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.2 -58.91 11.18 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -107.6 162.32 14.06 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.997 1.719 . . . . 0.0 112.048 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -108.17 -53.01 2.69 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.514 1.126 . . . . 0.0 112.974 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.59 91.19 0.08 OUTLIER Glycine 0 CA--C 1.541 1.664 0 O-C-N 121.67 -0.644 . . . . 0.0 114.058 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.84 161.6 44.14 Favored Glycine 0 CA--C 1.545 1.947 0 O-C-N 120.956 -1.32 . . . . 0.0 115.225 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.89 127.24 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.035 -1.273 . . . . 0.0 110.527 171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.57 -57.68 5.01 Favored Glycine 0 CA--C 1.546 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 113.759 -167.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.19 62.46 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.803 1.802 . . . . 0.0 112.562 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -91.58 63.83 4.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.871 2.069 . . . . 0.0 111.083 174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 -156.66 10.34 Favored Glycine 0 CA--C 1.545 1.969 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -169.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.54 77.85 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 1 C-N-CA 125.756 4.304 . . . . 0.0 117.196 -177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -159.93 43.52 0.21 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.416 1.886 . . . . 0.0 112.143 164.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.86 117.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 125.354 1.461 . . . . 0.0 114.313 -167.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.2 t -83.47 159.96 21.63 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.762 1.225 . . . . 0.0 114.267 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.54 157.57 35.26 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.612 1.165 . . . . 0.0 114.001 163.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.3 t -61.28 128.42 36.27 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.38 -74.34 0.57 Allowed Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.964 1.745 . . . . 0.0 112.8 164.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 t -151.71 -42.31 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.121 1.768 . . . . 0.0 113.365 163.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.2 p -138.02 118.89 14.2 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.284 1.834 . . . . 0.0 114.964 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.9 87.12 0.14 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 120.398 -1.439 . . . . 0.0 110.315 162.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.09 145.36 43.8 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -157.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.85 127.52 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 126.967 2.107 . . . . 0.0 115.1 -172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.28 -44.4 10.27 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.175 0.988 . . . . 0.0 110.712 161.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -145.1 156.18 54.75 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.872 2.469 . . . . 0.0 108.889 164.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -42.7 -44.81 8.74 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.649 2.9 . . . . 0.0 116.85 -171.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -84.11 7.4 18.9 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.15 88.43 2.1 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.787 1.635 . . . . 0.0 111.742 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.3 t -87.17 112.53 22.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.874 1.669 . . . . 0.0 112.256 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -92.25 174.33 7.36 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 128.628 2.771 . . . . 0.0 110.739 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.5 100.55 11.31 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.385 -1.447 . . . . 0.0 113.638 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.593 1.157 . . . . 0.0 111.433 174.038 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -150.69 178.76 8.79 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.071 1.748 . . . . 0.0 111.601 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 t -44.15 95.1 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.772 1.629 . . . . 0.0 115.104 172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -75.79 -80.19 0.09 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.83 1.252 . . . . 0.0 111.592 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.85 119.13 20.19 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 111.776 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -46.61 -40.8 11.96 Favored Glycine 0 CA--C 1.548 2.102 0 O-C-N 121.009 -1.057 . . . . 0.0 115.304 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -82.54 138.87 34.15 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 121.206 -1.173 . . . . 0.0 112.246 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.6 -52.97 5.23 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.456 -0.778 . . . . 0.0 112.225 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.32 95.93 0.12 Allowed Glycine 0 CA--C 1.542 1.726 0 C-N-CA 123.97 0.795 . . . . 0.0 113.885 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 147.02 24.85 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.804 -1.409 . . . . 0.0 115.0 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.5 mt -46.1 106.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.618 1.567 . . . . 0.0 112.352 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.16 -49.35 0.86 Allowed Glycine 0 CA--C 1.544 1.88 0 O-C-N 120.953 -1.092 . . . . 0.0 114.104 -170.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.91 55.49 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 119.247 1.523 . . . . 0.0 111.959 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -80.17 59.66 3.41 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.236 1.814 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.94 -145.98 4.6 Favored Glycine 0 CA--C 1.546 2.004 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.89 76.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.279 1 C-N-CA 125.54 4.16 . . . . 0.0 116.456 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.2 t -165.51 42.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.8 2.04 . . . . 0.0 111.727 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -86.56 117.84 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.617 -1.302 . . . . 0.0 114.358 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 t -84.13 160.48 20.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.905 1.282 . . . . 0.0 113.684 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.87 30.19 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.712 -1.242 . . . . 0.0 113.258 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.2 t -60.91 169.53 1.89 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.95 30.95 50.22 Favored Glycine 0 CA--C 1.549 2.203 0 C-N-CA 125.711 1.624 . . . . 0.0 114.411 -165.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.4 m -154.96 157.21 37.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 129.016 2.926 . . . . 0.0 109.509 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 -160.56 0.74 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.019 1.281 . . . . 0.0 113.058 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.0 t -143.99 92.12 2.3 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.299 1.839 . . . . 0.0 109.608 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -107.17 120.66 42.72 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.118 2.167 . . . . 0.0 113.269 -160.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.19 85.33 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 127.499 2.32 . . . . 0.0 114.416 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.68 -48.68 74.67 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.454 -1.404 . . . . 0.0 111.622 166.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -140.74 152.17 65.08 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.789 2.036 . . . . 0.0 110.212 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.1 -47.35 17.09 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.752 2.968 . . . . 0.0 114.598 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -78.24 8.87 4.34 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 85.7 1.45 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.691 1.196 . . . . 0.0 112.327 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.6 t -88.89 119.12 29.11 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.654 1.581 . . . . 0.0 112.826 171.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -103.24 151.32 22.79 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 129.306 3.042 . . . . 0.0 113.25 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.5 t -80.24 67.6 6.12 Favored 'General case' 0 CA--C 1.555 1.153 0 O-C-N 120.454 -1.404 . . . . 0.0 114.397 -172.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.783 1.633 . . . . 0.0 109.808 163.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -86.65 78.52 9.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.135 1.774 . . . . 0.0 108.05 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -135.96 34.25 2.87 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.116 1.366 . . . . 0.0 111.115 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -76.49 72.62 3.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.763 1.625 . . . . 0.0 113.932 -166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.85 145.33 27.44 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.791 1.636 . . . . 0.0 113.424 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.13 -162.99 53.96 Favored Glycine 0 CA--C 1.546 1.985 0 O-C-N 120.914 -1.116 . . . . 0.0 115.105 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -73.18 121.06 19.67 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 120.444 -1.621 . . . . 0.0 113.902 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -62.35 -52.41 63.74 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.331 1.053 . . . . 0.0 111.379 165.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.72 -39.14 0.02 OUTLIER Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.235 1.398 . . . . 0.0 114.614 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.36 176.66 47.34 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.689 1.138 . . . . 0.0 112.197 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 mt -122.21 144.59 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.907 1.683 . . . . 0.0 109.031 164.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.37 -55.96 4.07 Favored Glycine 0 CA--C 1.542 1.74 0 O-C-N 120.45 -1.406 . . . . 0.0 112.111 -165.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -68.58 127.65 33.78 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.486 -1.008 . . . . 0.0 109.671 151.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -147.9 15.15 1.06 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.06 170.51 51.24 Favored Glycine 0 CA--C 1.547 2.043 0 O-C-N 121.212 -0.93 . . . . 0.0 114.552 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.96 71.21 2.82 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 124.055 3.17 . . . . 0.0 114.307 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -95.41 42.79 1.09 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.139 1.375 . . . . 0.0 112.201 160.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.62 106.94 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -162.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.7 t -54.21 -48.82 70.6 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.85 42.81 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -163.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -108.4 172.6 6.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.14 1.776 . . . . 0.0 112.816 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.58 -44.73 3.36 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 124.506 1.05 . . . . 0.0 113.176 -160.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m 95.73 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.35 1.86 . . . . 0.0 114.871 157.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.9 p -109.3 159.83 16.64 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.292 2.237 . . . . 0.0 112.06 167.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -177.45 106.2 0.06 Allowed 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 124.502 1.121 . . . . 0.0 113.016 -159.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.59 121.42 44.73 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -167.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.63 101.93 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 126.458 1.903 . . . . 0.0 113.512 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -73.21 -69.9 0.39 Allowed 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.511 -1.368 . . . . 0.0 110.945 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -110.34 152.61 43.37 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.48 1.512 . . . . 0.0 110.32 157.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -54.04 154.88 16.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.807 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.279 82.9 m-85 78.36 -40.39 0.28 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.842 1.657 . . . . 0.0 113.628 -166.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -83.88 134.76 34.68 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 120.715 -1.241 . . . . 0.0 112.705 168.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -142.85 108.28 5.04 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.49 -1.381 . . . . 0.0 112.361 171.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -94.02 156.02 16.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.021 2.528 . . . . 0.0 114.196 -166.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 t -78.28 61.16 2.68 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.467 1.507 . . . . 0.0 112.745 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.254 1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 110.769 166.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.049 -1.453 . . . . 0.0 113.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 165.95 131.0 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 129.372 3.069 . . . . 0.0 109.008 -171.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -106.25 -172.91 2.17 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.951 1.25 . . . . 0.0 112.903 172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -138.43 -169.35 2.58 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 126.05 1.74 . . . . 0.0 113.624 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.15 75.93 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -169.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.43 172.41 36.06 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 128.513 2.959 . . . . 0.0 111.795 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -71.07 149.11 46.84 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -162.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 t -89.87 -57.15 2.96 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.1 1.76 . . . . 0.0 114.511 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 109.51 3.37 Favored Glycine 0 CA--C 1.544 1.846 0 C-N-CA 125.085 1.326 . . . . 0.0 111.193 -155.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.59 -129.42 1.07 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 120.635 -1.509 . . . . 0.0 115.657 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 mt -52.52 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.184 0.993 . . . . 0.0 112.149 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.24 -58.7 4.83 Favored Glycine 0 CA--C 1.543 1.829 0 O-C-N 120.896 -1.127 . . . . 0.0 114.832 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.07 84.81 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.263 1.532 . . . . 0.0 111.245 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -97.77 8.61 44.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.275 2.63 . . . . 0.0 114.294 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.57 176.68 54.27 Favored Glycine 0 CA--C 1.552 2.365 0 O-C-N 120.462 -1.399 . . . . 0.0 115.25 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -54.79 75.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 125.157 3.905 . . . . 0.0 116.449 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -137.8 53.08 1.85 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.419 1.888 . . . . 0.0 110.448 168.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.26 131.74 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.473 1.909 . . . . 0.0 114.131 -160.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.9 p -98.09 -171.32 2.13 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.101 1.76 . . . . 0.0 115.272 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.56 127.93 34.6 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.104 1.362 . . . . 0.0 113.427 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 t -63.23 173.01 1.62 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.32 50.9 62.54 Favored Glycine 0 CA--C 1.546 1.992 0 C-N-CA 124.541 1.067 . . . . 0.0 112.893 -162.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -159.15 147.35 17.85 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 130.429 3.492 . . . . 0.0 108.271 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.8 p -97.31 156.39 16.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 121.934 2.152 . . . . 0.0 116.272 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -94.06 69.06 3.81 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.175 2.19 . . . . 0.0 112.362 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.36 155.45 32.29 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.302 1.441 . . . . 0.0 114.162 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.91 139.0 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.982 1.713 . . . . 0.0 113.222 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.58 -65.63 0.98 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.272 1.029 . . . . 0.0 110.242 167.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.17 150.67 51.84 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.973 1.709 . . . . 0.0 110.738 166.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -53.38 143.52 53.85 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.467 2.112 . . . . 0.0 111.548 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.332 99.0 m-85 80.07 -29.13 0.13 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.575 1.95 . . . . 0.0 116.226 -169.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -88.58 151.07 22.73 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.27 -1.519 . . . . 0.0 111.793 162.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.3 t -154.83 131.2 10.44 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.803 -1.186 . . . . 0.0 112.854 170.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -105.6 147.49 28.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 127.832 2.453 . . . . 0.0 112.819 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.0 t -100.27 92.23 5.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.106 1.362 . . . . 0.0 113.032 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.553 1.08 0 C-N-CA 127.042 2.137 . . . . 0.0 114.55 -171.444 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 117.861 -1.066 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -87.02 -138.39 0.09 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.865 1.666 . . . . 0.0 109.326 152.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 t -95.33 179.93 5.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 113.029 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -107.59 -84.16 0.53 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.471 1.508 . . . . 0.0 108.729 162.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -44.64 130.91 6.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.039 1.336 . . . . 0.0 114.165 166.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.06 -171.76 24.9 Favored Glycine 0 CA--C 1.548 2.13 0 C-N-CA 125.705 1.621 . . . . 0.0 115.438 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -75.25 117.33 16.95 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 121.254 -1.145 . . . . 0.0 113.275 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -96.36 -33.84 11.78 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.09 81.55 0.05 OUTLIER Glycine 0 CA--C 1.538 1.474 0 O-C-N 121.574 -0.704 . . . . 0.0 114.355 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.9 -150.33 19.57 Favored Glycine 0 CA--C 1.548 2.101 0 C-N-CA 124.262 0.934 . . . . 0.0 115.124 173.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.3 mt -112.29 104.59 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.552 1.941 . . . . 0.0 108.079 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.38 77.92 0.63 Allowed Glycine 0 CA--C 1.55 2.258 0 O-C-N 120.968 -1.082 . . . . 0.0 112.581 -158.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -127.45 152.29 47.73 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.022 1.729 . . . . 0.0 115.515 -161.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -76.25 61.27 1.61 Allowed 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.84 -113.25 2.93 Favored Glycine 0 CA--C 1.548 2.151 0 C-N-CA 125.102 1.334 . . . . 0.0 115.347 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -62.48 168.81 9.16 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 CA-C-N 120.972 2.386 . . . . 0.0 114.884 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.2 m -118.37 51.03 1.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.113 1.365 . . . . 0.0 111.169 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -172.33 155.88 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 120.81 -1.181 . . . . 0.0 113.459 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.7 t -97.15 -178.86 4.33 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 126.779 2.031 . . . . 0.0 113.353 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.02 -72.76 0.14 Allowed 'General case' 0 CA--C 1.548 0.892 0 O-C-N 119.233 -2.167 . . . . 0.0 114.144 168.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 t 172.74 175.96 0.1 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 128.107 2.563 . . . . 0.0 113.747 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.98 -79.9 0.03 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 125.702 1.62 . . . . 0.0 112.381 -165.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 36' ' ' LEU . 59.8 m -63.29 146.76 52.79 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.167 1.387 . . . . 0.0 113.825 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.9 p -98.8 158.8 15.39 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.301 1.84 . . . . 0.0 114.755 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -71.69 108.32 4.97 Favored 'General case' 0 CA--C 1.562 1.433 0 O-C-N 119.823 -1.798 . . . . 0.0 112.832 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.14 148.05 32.51 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.571 1.549 . . . . 0.0 113.991 -166.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.32 107.16 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 O-C-N 119.809 -1.807 . . . . 0.0 115.464 -167.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.46 -63.05 1.19 Allowed 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.921 -1.112 . . . . 0.0 110.942 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.3 144.04 51.81 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.475 1.91 . . . . 0.0 109.317 165.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -43.76 -44.33 11.53 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.404 3.403 . . . . 0.0 115.41 -167.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -62.33 -33.55 74.91 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.19 90.2 2.71 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.595 1.558 . . . . 0.0 112.455 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -78.53 142.06 37.67 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.661 1.984 . . . . 0.0 114.902 169.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -131.92 142.07 49.54 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 129.424 3.09 . . . . 0.0 110.713 -171.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 t -100.55 103.99 15.33 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 120.158 -1.589 . . . . 0.0 113.086 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' C ' HG21 ' A' ' 23' ' ' THR . 7.9 mp . . . . . 0 C--O 1.256 1.413 0 C-N-CA 127.321 2.248 . . . . 0.0 113.723 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.04 173.08 11.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.238 2.215 . . . . 0.0 111.157 -169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -59.75 86.55 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.713 1.205 . . . . 0.0 114.229 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -118.42 -25.82 6.41 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.78 170.29 9.55 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.366 1.466 . . . . 0.0 113.422 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -107.27 0.49 Allowed Glycine 0 CA--C 1.549 2.168 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 -173.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -75.64 104.28 6.12 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 121.084 -1.245 . . . . 0.0 112.732 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.5 p -69.56 -38.7 77.54 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.4 66.13 0.02 OUTLIER Glycine 0 CA--C 1.541 1.706 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.09 -177.19 14.74 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 121.442 -1.034 . . . . 0.0 115.487 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 121.109 -1.23 . . . . 0.0 110.947 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.33 -51.96 4.46 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 120.611 -1.306 . . . . 0.0 112.509 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.24 34.68 0.09 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.829 1.252 . . . . 0.0 113.379 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -86.8 56.74 4.14 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.212 -1.555 . . . . 0.0 112.648 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.93 -157.17 8.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.996 1.158 . . . . 0.0 115.996 -169.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -59.42 68.62 0.06 OUTLIER 'Trans proline' 0 CA--C 1.552 1.41 1 C-N-CA 125.66 4.24 . . . . 0.0 117.3 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -131.13 45.42 2.81 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.51 1.924 . . . . 0.0 110.362 164.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.71 128.64 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.18 153.27 41.72 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.304 1.042 . . . . 0.0 113.446 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.12 155.9 19.44 Favored 'General case' 0 CA--C 1.555 1.139 0 O-C-N 120.995 -1.066 . . . . 0.0 113.262 168.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -52.01 146.09 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.52 -50.95 0.87 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.944 1.735 . . . . 0.0 109.153 -150.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 69.61 8.81 6.94 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 156.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -71.16 47.33 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 128.521 2.728 . . . . 0.0 114.366 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -69.62 80.21 0.42 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.024 1.73 . . . . 0.0 112.925 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -173.09 4.51 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.469 2.707 . . . . 0.0 114.083 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.3 p -141.01 133.59 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.435 1.894 . . . . 0.0 113.293 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mp -94.37 -64.77 1.04 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.261 1.024 . . . . 0.0 111.322 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -113.04 138.14 22.15 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.976 1.311 . . . . 0.0 110.253 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -36.34 -38.85 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.718 4.279 . . . . 0.0 119.162 -171.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -58.95 -36.58 75.04 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -92.38 164.17 13.59 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.449 2.699 . . . . 0.0 114.254 -166.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 t -156.05 125.62 6.32 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.627 -1.296 . . . . 0.0 114.261 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -130.12 146.51 51.77 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.504 1.521 . . . . 0.0 114.387 -170.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.0 t -92.28 124.92 36.71 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.216 1.807 . . . . 0.0 111.91 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 125.355 1.462 . . . . 0.0 112.914 -177.132 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 117.184 -1.389 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -57.46 77.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.902 2.137 . . . . 0.0 109.761 145.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -125.02 -74.19 0.62 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 127.388 2.275 . . . . 0.0 108.637 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -52.83 -65.66 0.52 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 122.451 1.119 . . . . 0.0 112.341 167.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.29 65.41 8.27 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 120.504 -1.372 . . . . 0.0 111.63 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 132.05 2.74 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.534 1.54 . . . . 0.0 113.055 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -87.42 144.69 26.62 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.964 -1.315 . . . . 0.0 111.788 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.4 p -92.87 -55.46 3.35 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.46 -1.4 . . . . 0.0 112.883 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.17 101.64 0.17 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.224 1.393 . . . . 0.0 111.722 -175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.92 179.38 35.37 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 116.827 1.491 . . . . 0.0 116.827 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.72 89.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 121.347 -1.09 . . . . 0.0 111.493 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.82 -23.53 14.57 Favored Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.091 1.329 . . . . 0.0 115.205 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.95 69.4 0.73 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.01 1.324 . . . . 0.0 111.656 -164.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -84.06 -29.42 26.87 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.25 -177.25 12.29 Favored Glycine 0 CA--C 1.551 2.297 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -48.95 78.82 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.467 1 C-N-CA 125.768 4.312 . . . . 0.0 117.157 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.8 t -132.25 7.06 4.22 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.888 2.075 . . . . 0.0 113.992 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.38 137.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -163.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.4 p -64.58 175.14 1.49 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.856 2.063 . . . . 0.0 116.494 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.03 -173.34 2.8 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.857 1.263 . . . . 0.0 112.998 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 t -36.79 107.28 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.41 -47.66 0.03 OUTLIER Glycine 0 CA--C 1.547 2.055 0 C-N-CA 125.374 1.464 . . . . 0.0 114.336 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.322 2.7 t 62.42 -34.35 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 p -65.83 164.19 15.31 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.106 1.321 . . . . 0.0 113.472 160.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -164.58 143.53 7.09 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.308 1.443 . . . . 0.0 112.906 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -176.47 3.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.291 1.436 . . . . 0.0 114.256 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.91 113.94 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.686 1.594 . . . . 0.0 114.336 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.59 -58.92 3.0 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.38 1.086 . . . . 0.0 110.437 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -131.06 142.56 46.03 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.72 2.008 . . . . 0.0 109.895 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -47.75 -36.07 25.09 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.966 3.111 . . . . 0.0 115.825 -170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.3 3.39 21.17 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.94 93.25 2.31 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 127.07 2.148 . . . . 0.0 112.668 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.2 t -85.32 121.8 28.57 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 120.303 -1.498 . . . . 0.0 113.783 171.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -108.14 139.3 43.01 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 127.746 2.418 . . . . 0.0 113.368 -169.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.7 t -78.92 64.32 3.84 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.219 1.807 . . . . 0.0 115.275 -158.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.418 2.287 . . . . 0.0 113.601 171.505 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 117.511 -1.233 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -113.85 163.73 14.69 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.05 1.74 . . . . 0.0 112.514 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -83.31 42.94 0.85 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.564 1.545 . . . . 0.0 113.905 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -22.99 -54.02 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 118.692 2.849 . . . . 0.0 118.692 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.85 101.11 8.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.836 1.655 . . . . 0.0 112.066 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -47.1 -59.5 5.63 Favored Glycine 0 CA--C 1.542 1.748 0 C-N-CA 125.476 1.513 . . . . 0.0 115.424 -174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.47 111.75 12.27 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 120.81 -1.406 . . . . 0.0 112.079 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -61.75 -56.28 21.22 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.87 1.668 . . . . 0.0 115.266 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.34 54.96 0.02 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.649 1.118 . . . . 0.0 114.127 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.92 41.77 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -168.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.5 114.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 O-C-N 120.601 -1.529 . . . . 0.0 111.327 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.31 -63.03 0.63 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.936 1.255 . . . . 0.0 111.692 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -70.69 50.64 0.13 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.491 1.516 . . . . 0.0 112.19 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 m -98.18 71.78 2.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.027 1.331 . . . . 0.0 113.284 -161.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.05 -174.54 37.01 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -61.77 71.33 0.1 OUTLIER 'Trans proline' 0 CA--C 1.549 1.26 1 C-N-CA 125.761 4.307 . . . . 0.0 115.073 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.9 p -115.75 17.1 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.585 2.754 . . . . 0.0 113.377 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.5 149.64 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 126.216 1.806 . . . . 0.0 115.317 -162.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.49 177.98 1.76 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.06 -158.61 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.5 p -67.81 67.14 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 O-C-N 120.073 -1.642 . . . . 0.0 114.181 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.01 -47.67 0.2 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.106 2.289 . . . . 0.0 112.471 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 t 50.48 24.28 1.54 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.251 2.22 . . . . 0.0 116.609 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.8 p -75.86 45.23 0.33 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.884 1.674 . . . . 0.0 112.29 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.71 71.68 0.74 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.042 2.537 . . . . 0.0 112.289 -164.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -178.51 5.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.313 2.245 . . . . 0.0 113.75 -175.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.23 141.76 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.969 1.308 . . . . 0.0 112.933 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -94.57 -77.1 0.47 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.98 0.912 . . . . 0.0 109.915 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -97.21 146.45 31.37 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.577 1.551 . . . . 0.0 111.327 164.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -40.01 -48.64 3.79 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.958 3.106 . . . . 0.0 116.123 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -75.3 54.06 0.69 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.665 1.186 . . . . 0.0 113.477 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -166.65 178.92 5.7 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 127.773 2.429 . . . . 0.0 110.124 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.6 t 178.53 134.71 0.08 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.289 1.835 . . . . 0.0 110.73 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -132.52 140.63 48.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.063 1.345 . . . . 0.0 113.406 -169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 t -93.61 136.84 33.49 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.887 2.075 . . . . 0.0 111.388 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.789 1.636 . . . . 0.0 110.916 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -108.29 -37.7 5.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.193 1.797 . . . . 0.0 112.723 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 p 54.49 43.17 30.74 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.73 129.72 42.39 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.193 1.397 . . . . 0.0 111.637 165.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.19 68.94 0.34 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.176 1.39 . . . . 0.0 114.714 -171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.52 -71.41 0.2 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.028 1.775 . . . . 0.0 114.837 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.22 117.46 6.09 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 120.989 -1.301 . . . . 0.0 112.162 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -54.82 -36.39 64.93 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.81 -44.97 0.48 Allowed Glycine 0 CA--C 1.544 1.905 0 C-N-CA 124.364 0.983 . . . . 0.0 115.097 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.62 108.1 0.56 Allowed Glycine 0 CA--C 1.543 1.814 0 C-N-CA 125.08 1.324 . . . . 0.0 113.578 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.254 15.3 mt -44.47 133.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -171.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.29 -60.87 0.32 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -131.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -59.25 77.2 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.138 0.97 . . . . 0.0 110.097 142.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -135.91 -31.36 0.93 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.288 2.635 . . . . 0.0 111.957 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.27 -155.8 29.87 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 125.623 1.582 . . . . 0.0 113.976 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.33 66.86 7.11 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.625 2.884 . . . . 0.0 112.647 -174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -131.96 54.44 1.93 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.141 169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.49 143.89 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 126.468 1.907 . . . . 0.0 113.305 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 p -81.96 -32.35 30.78 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -171.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.87 -107.33 0.37 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.509 1.524 . . . . 0.0 114.05 -162.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 t -173.83 113.19 0.2 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.967 1.307 . . . . 0.0 111.394 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.23 -53.18 0.47 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -157.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.267 6.5 m 103.1 6.9 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.322 2.249 . . . . 0.0 113.872 147.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 p -102.2 105.24 15.88 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.501 2.32 . . . . 0.0 112.993 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.7 t -72.38 75.28 1.02 Allowed 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.796 -1.815 . . . . 0.0 109.367 163.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.59 172.4 2.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.712 2.405 . . . . 0.0 114.507 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.48 97.71 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 125.707 1.603 . . . . 0.0 112.82 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.92 -45.09 62.41 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.769 -1.207 . . . . 0.0 111.991 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -145.58 155.98 52.93 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 126.707 2.003 . . . . 0.0 109.275 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -53.77 123.17 12.76 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.694 1.596 . . . . 0.0 110.658 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . 0.402 84.6 m-85 92.49 -48.27 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 129.032 2.933 . . . . 0.0 115.802 -167.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.72 90.38 1.84 Allowed 'General case' 0 N--CA 1.479 1.004 0 O-C-N 120.101 -1.624 . . . . 0.0 112.552 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -87.28 152.33 22.39 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 159.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -131.94 136.4 47.33 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.466 1.506 . . . . 0.0 113.168 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.22 85.05 5.11 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.703 1.601 . . . . 0.0 114.076 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.557 1.219 0 C-N-CA 125.652 1.581 . . . . 0.0 110.781 173.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -137.56 124.01 20.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.801 1.24 . . . . 0.0 112.053 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.3 m -69.35 -69.02 0.36 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.419 1.088 . . . . 0.0 109.421 162.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.53 103.49 2.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 112.804 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.7 -136.36 0.07 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.595 1.158 . . . . 0.0 113.978 -172.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.31 -129.77 6.4 Favored Glycine 0 CA--C 1.542 1.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.982 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -74.44 155.05 38.45 Favored 'General case' 0 CA--C 1.559 1.303 0 O-C-N 121.137 -1.213 . . . . 0.0 112.973 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 t -100.53 -67.2 0.87 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.531 1.132 . . . . 0.0 111.487 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 80.99 0.05 OUTLIER Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.139 1.352 . . . . 0.0 112.693 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.75 28.25 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -165.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -50.12 105.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.483 1.513 . . . . 0.0 112.525 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.54 -53.17 0.59 Allowed Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.295 1.426 . . . . 0.0 112.841 -170.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.1 57.61 1.12 Allowed 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 122.765 1.269 . . . . 0.0 110.85 167.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.4 m -81.5 61.18 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.941 1.696 . . . . 0.0 112.427 -172.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.27 177.74 27.26 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 -174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.28 69.62 4.89 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.253 3.302 . . . . 0.0 113.012 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -114.47 55.03 0.75 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.123 2.169 . . . . 0.0 111.007 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 p -119.26 135.52 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -158.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.63 131.49 38.99 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 102.56 0.18 Allowed 'General case' 0 CA--C 1.555 1.172 0 O-C-N 120.51 -1.369 . . . . 0.0 113.357 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.263 9.4 t 13.11 129.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 131.692 3.997 . . . . 0.0 120.421 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.19 -43.42 0.63 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 128.9 3.143 . . . . 0.0 109.078 -155.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.271 5.7 t 65.06 18.91 11.68 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 149.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.3 p -85.33 65.73 9.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.343 3.057 . . . . 0.0 112.14 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.9 104.61 1.13 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.861 1.265 . . . . 0.0 114.195 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.2 164.61 13.65 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.48 2.312 . . . . 0.0 112.014 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -139.46 104.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.545 -1.972 . . . . 0.0 115.548 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.11 -65.3 0.67 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.157 1.783 . . . . 0.0 113.529 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -120.27 144.9 39.08 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.034 1.734 . . . . 0.0 109.143 165.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -38.05 -55.69 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.739 3.626 . . . . 0.0 116.109 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -72.09 61.19 0.43 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.659 1.184 . . . . 0.0 113.52 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -172.99 179.07 2.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.159 2.584 . . . . 0.0 110.461 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.9 t -174.3 129.74 0.36 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.795 1.238 . . . . 0.0 112.84 156.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -121.68 142.09 50.5 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.721 2.408 . . . . 0.0 112.047 -172.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -90.92 104.79 17.34 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.401 1.081 . . . . 0.0 111.742 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.937 1.695 . . . . 0.0 114.132 -175.196 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 118.119 -0.943 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -68.82 63.04 0.11 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 123.208 1.48 . . . . 0.0 113.02 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -30.22 70.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.43 2.292 . . . . 0.0 112.171 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -123.33 140.31 53.15 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.395 2.278 . . . . 0.0 109.501 161.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 92.94 3.69 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.82 -172.2 47.3 Favored Glycine 0 CA--C 1.545 1.961 0 C-N-CA 125.64 1.59 . . . . 0.0 115.353 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -101.54 158.5 16.04 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.742 1.617 . . . . 0.0 113.69 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 m -98.46 -44.11 6.63 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.6 1.56 . . . . 0.0 114.273 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.39 91.27 0.68 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.255 1.883 . . . . 0.0 109.922 -159.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.0 -176.36 22.86 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 -163.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -52.4 128.74 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 121.435 -1.038 . . . . 0.0 110.832 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.5 -56.35 1.62 Allowed Glycine 0 CA--C 1.545 1.956 0 O-C-N 120.937 -1.102 . . . . 0.0 114.352 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 60.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.13 1.372 . . . . 0.0 113.034 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -84.51 79.69 9.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.385 1.874 . . . . 0.0 111.634 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.45 -173.42 44.59 Favored Glycine 0 CA--C 1.543 1.828 0 O-C-N 121.286 -0.884 . . . . 0.0 115.09 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.53 73.93 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.331 0 C-N-CA 125.244 3.963 . . . . 0.0 116.459 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t -130.39 67.63 1.48 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.287 1.835 . . . . 0.0 110.07 164.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.76 126.93 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.595 1.958 . . . . 0.0 113.966 -165.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.5 p -78.49 169.66 17.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.32 157.07 29.27 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.488 -0.757 . . . . 0.0 111.17 151.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -51.79 112.91 0.85 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.06 0.49 Allowed Glycine 0 CA--C 1.549 2.218 0 C-N-CA 124.287 0.946 . . . . 0.0 112.811 151.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 t -117.43 -40.15 3.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 128.603 2.761 . . . . 0.0 111.79 167.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 p -144.39 -125.1 0.08 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.304 1.842 . . . . 0.0 112.864 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -167.56 107.9 0.58 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 126.877 2.071 . . . . 0.0 111.556 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -81.8 155.65 25.31 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 126.715 2.006 . . . . 0.0 112.316 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 p -127.91 120.04 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 O-C-N 119.679 -1.888 . . . . 0.0 112.849 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.85 -55.53 3.92 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.474 1.109 . . . . 0.0 112.904 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-20 -79.01 -170.14 0.23 Allowed Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.944 1.298 . . . . 0.0 110.881 164.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.67 -62.23 0.11 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 121.023 1.148 . . . . 0.0 109.803 135.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.62 75.01 1.51 Allowed 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.402 3.7 p90 -171.09 -152.24 0.08 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.31 2.244 . . . . 0.0 111.819 135.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 t -166.39 112.79 0.84 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.288 1.404 . . . . 0.0 112.727 161.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -91.3 129.3 37.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.996 2.919 . . . . 0.0 114.181 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -73.66 62.26 0.78 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.667 -1.158 . . . . 0.0 108.401 166.598 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -109.62 61.74 0.6 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.537 1.535 . . . . 0.0 110.033 169.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -54.63 84.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 119.334 3.087 . . . . 0.0 119.334 -148.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -55.12 103.38 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.846 1.259 . . . . 0.0 112.82 163.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.73 59.64 0.88 Allowed 'General case' 0 CA--C 1.554 1.107 0 O-C-N 120.617 -1.302 . . . . 0.0 114.129 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.89 -78.3 0.06 OUTLIER Glycine 0 CA--C 1.542 1.744 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -69.79 140.72 53.39 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 120.575 -1.544 . . . . 0.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.9 t -86.41 -54.11 4.61 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.737 1.215 . . . . 0.0 112.37 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.71 89.48 0.07 OUTLIER Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.291 1.424 . . . . 0.0 111.746 -170.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.21 154.02 47.3 Favored Glycine 0 CA--C 1.542 1.739 0 O-C-N 121.122 -1.223 . . . . 0.0 115.329 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.72 123.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 O-C-N 120.863 -1.375 . . . . 0.0 110.584 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.14 -59.46 3.11 Favored Glycine 0 CA--C 1.544 1.855 0 O-C-N 121.236 -0.915 . . . . 0.0 113.165 -166.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.19 58.3 0.7 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.056 1.428 . . . . 0.0 112.986 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -84.62 74.46 10.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.146 1.778 . . . . 0.0 110.728 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.54 -154.87 11.01 Favored Glycine 0 CA--C 1.546 2.009 0 O-C-N 121.345 -0.847 . . . . 0.0 114.609 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.86 74.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 124.953 3.769 . . . . 0.0 117.327 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -143.73 46.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.934 1.294 . . . . 0.0 112.642 158.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.28 124.07 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.944 0.898 . . . . 0.0 112.892 -175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.3 p -77.99 -142.34 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 126.08 1.752 . . . . 0.0 115.249 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 -170.92 2.77 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 119.954 -1.716 . . . . 0.0 114.407 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 t -75.75 -179.3 4.67 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.072 -1.018 . . . . 0.0 112.464 163.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.01 -48.54 1.44 Allowed Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.135 1.35 . . . . 0.0 113.553 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.7 m 76.35 42.38 0.18 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.322 1.449 . . . . 0.0 113.964 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.3 p -90.28 158.0 17.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.959 1.304 . . . . 0.0 111.788 162.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.6 t -170.72 80.69 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.17 -0.956 . . . . 0.0 113.251 -160.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.43 163.71 15.16 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 127.729 2.412 . . . . 0.0 113.168 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.0 99.88 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 119.729 -1.857 . . . . 0.0 114.79 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.29 -45.17 73.77 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 120.983 -1.073 . . . . 0.0 112.221 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -148.79 151.65 35.71 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.816 2.047 . . . . 0.0 109.322 165.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.33 -40.54 35.78 Favored 'Trans proline' 0 CA--C 1.549 1.26 0 C-N-CA 123.39 2.727 . . . . 0.0 115.771 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -77.73 -4.06 44.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -134.7 88.46 2.44 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 125.254 1.422 . . . . 0.0 113.738 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -83.43 128.49 34.55 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.873 -1.142 . . . . 0.0 113.339 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -116.24 137.0 52.51 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 128.354 2.662 . . . . 0.0 112.353 -171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.16 66.21 1.64 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.412 1.485 . . . . 0.0 114.156 -172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.379 1.872 . . . . 0.0 110.188 164.508 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -171.19 154.92 4.16 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 129.96 3.304 . . . . 0.0 107.756 171.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -121.86 143.42 49.43 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -165.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -101.52 154.3 18.96 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.176 -1.577 . . . . 0.0 112.916 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.56 67.16 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -163.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.77 161.79 20.13 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 128.117 2.77 . . . . 0.0 113.364 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -67.71 134.17 50.59 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 120.174 -1.78 . . . . 0.0 115.1 -171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.8 -35.94 8.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.226 1.41 . . . . 0.0 113.057 165.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 93.1 0.1 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.889 0.757 . . . . 0.0 112.614 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.79 106.37 2.53 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 164.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.1 111.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 119.575 1.687 . . . . 0.0 112.257 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.01 41.67 3.0 Favored Glycine 0 CA--C 1.547 2.067 0 O-C-N 121.374 -0.829 . . . . 0.0 112.892 -155.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.5 133.5 41.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.884 1.674 . . . . 0.0 114.197 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.9 t -70.94 59.02 0.22 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.979 1.312 . . . . 0.0 113.35 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.58 -149.51 18.76 Favored Glycine 0 CA--C 1.551 2.283 0 C-N-CA 126.099 1.809 . . . . 0.0 114.713 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.36 137.89 64.71 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 124.122 3.215 . . . . 0.0 115.483 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -103.89 70.83 1.02 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.088 1.355 . . . . 0.0 111.727 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.81 143.83 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 120.867 -1.146 . . . . 0.0 113.973 -167.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.4 t -139.05 172.97 12.07 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.639 1.976 . . . . 0.0 111.284 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.65 151.43 47.39 Favored 'General case' 0 CA--C 1.553 1.06 0 O-C-N 120.45 -1.406 . . . . 0.0 114.604 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -66.47 168.35 9.2 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 -49.88 1.9 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.948 1.737 . . . . 0.0 112.448 -163.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.477 HG21 ' SG ' ' A' ' 35' ' ' CYS . 95.6 m -90.51 155.69 18.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.52 2.728 . . . . 0.0 113.48 -176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -114.09 161.91 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.013 1.325 . . . . 0.0 113.687 164.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.5 t -81.36 88.4 6.1 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 120.589 -1.319 . . . . 0.0 113.155 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 125.35 35.42 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.434 1.893 . . . . 0.0 114.917 -163.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.29 112.63 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 C-N-CA 126.529 1.932 . . . . 0.0 115.513 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.07 -48.28 45.33 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.389 1.09 . . . . 0.0 111.451 165.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -152.97 138.88 11.97 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.743 2.017 . . . . 0.0 108.188 162.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -22.87 -55.63 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 1 C-N-CA 125.48 4.12 . . . . 0.0 118.488 -170.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -70.7 -15.71 62.73 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.74 106.38 15.15 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.475 1.51 . . . . 0.0 112.57 157.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 t -108.22 131.11 55.02 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.138 0.97 . . . . 0.0 113.116 159.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -123.17 154.75 38.27 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 129.978 3.311 . . . . 0.0 112.021 -164.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 23' ' ' THR . 8.9 t -102.6 101.29 11.43 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.491 1.516 . . . . 0.0 113.855 -171.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HG23 ' A' ' 23' ' ' THR . 9.7 mp . . . . . 0 C--O 1.261 1.678 0 C-N-CA 126.047 1.739 . . . . 0.0 112.682 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.159 -0.924 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -121.62 -52.57 2.02 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.891 1.276 . . . . 0.0 113.658 -170.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 p 39.91 51.05 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 161.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -94.86 -56.34 2.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.849 1.659 . . . . 0.0 112.148 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.35 94.68 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 O-C-N 120.969 -1.082 . . . . 0.0 112.899 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -39.9 -50.98 3.38 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 117.617 1.807 . . . . 0.0 117.617 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.45 117.62 14.34 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 120.773 -1.428 . . . . 0.0 113.528 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -68.14 -54.18 19.88 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.258 -0.901 . . . . 0.0 112.62 166.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.28 90.51 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.387 0.994 . . . . 0.0 113.377 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.19 148.68 47.92 Favored Glycine 0 CA--C 1.547 2.084 0 O-C-N 121.398 -1.06 . . . . 0.0 115.723 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.86 86.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 168.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.58 58.21 1.86 Allowed Glycine 0 CA--C 1.542 1.765 0 O-C-N 121.553 -0.717 . . . . 0.0 111.65 -163.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -38.29 106.64 0.05 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 127.514 2.326 . . . . 0.0 116.802 -166.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 m -73.78 58.58 0.63 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.772 1.629 . . . . 0.0 111.843 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.56 -175.09 22.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 125.829 1.68 . . . . 0.0 112.954 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.75 147.6 24.78 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 122.354 2.036 . . . . 0.0 112.402 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.7 m -88.85 69.23 8.6 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.425 1.49 . . . . 0.0 111.226 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 p -157.05 114.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -157.75 160.02 37.43 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.806 1.243 . . . . 0.0 112.401 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.99 22.07 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.997 -1.065 . . . . 0.0 111.598 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -63.73 150.68 43.92 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.791 -1.193 . . . . 0.0 113.298 168.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.64 -72.03 0.17 Allowed Glycine 0 CA--C 1.545 1.924 0 C-N-CA 127.574 2.512 . . . . 0.0 110.204 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 t -150.32 -47.22 0.13 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.244 2.617 . . . . 0.0 113.441 162.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.7 p -138.22 137.98 38.06 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.2 t -77.11 80.82 3.63 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 119.826 -1.796 . . . . 0.0 109.986 166.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 133.16 39.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.377 1.871 . . . . 0.0 114.946 -157.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 p -86.89 109.36 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 126.645 1.978 . . . . 0.0 115.269 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.36 -60.53 2.19 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 122.516 1.15 . . . . 0.0 110.665 168.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -131.31 136.61 28.96 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.518 1.927 . . . . 0.0 108.628 163.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.92 -55.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.362 1 C-N-CA 126.509 4.806 . . . . 0.0 118.399 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -57.52 -46.68 83.52 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 100.04 11.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.487 1.515 . . . . 0.0 111.604 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 t -99.53 132.08 45.1 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.219 1.408 . . . . 0.0 113.704 164.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -117.98 146.51 43.96 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 128.084 2.554 . . . . 0.0 113.564 -166.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.3 t -77.83 70.99 4.28 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.297 1.839 . . . . 0.0 113.02 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--O 1.248 1.01 0 C-N-CA 125.755 1.622 . . . . 0.0 110.712 167.222 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 117.82 -1.086 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -129.16 -176.9 4.02 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.303 1.441 . . . . 0.0 113.564 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -65.41 178.45 0.94 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.726 2.01 . . . . 0.0 115.442 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -152.88 -89.93 0.05 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.365 1.466 . . . . 0.0 110.596 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.24 143.79 43.22 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 120.907 -1.121 . . . . 0.0 112.576 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.68 -45.32 94.8 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -75.17 139.6 42.77 Favored 'General case' 0 CA--C 1.553 1.087 0 O-C-N 121.031 -1.276 . . . . 0.0 113.628 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.9 t -94.45 -62.53 1.31 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.983 1.313 . . . . 0.0 112.206 169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.38 81.53 0.06 OUTLIER Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.37 0.908 . . . . 0.0 115.37 -166.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.0 -167.12 4.83 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.2 mt -82.34 135.89 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 121.095 -1.238 . . . . 0.0 110.063 167.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.94 -56.41 4.94 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 120.155 -1.59 . . . . 0.0 112.174 -172.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.1 58.48 0.36 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 122.228 1.013 . . . . 0.0 110.41 157.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.3 m -75.43 80.91 2.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.585 1.954 . . . . 0.0 114.946 -150.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.12 -177.29 20.88 Favored Glycine 0 CA--C 1.548 2.141 0 C-N-CA 125.493 1.521 . . . . 0.0 115.83 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.68 78.01 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 1 C-N-CA 125.711 4.274 . . . . 0.0 115.011 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.48 -17.12 14.86 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.976 2.111 . . . . 0.0 114.208 -174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.2 p -151.39 169.19 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' H ' HG22 ' A' ' 18' ' ' VAL 0.32 0.7 OUTLIER 90.85 -171.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 129.385 3.074 . . . . 0.0 114.308 -170.787 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.39 157.0 18.8 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.988 1.315 . . . . 0.0 114.106 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -58.46 135.43 57.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.68 -40.97 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.539 2.019 . . . . 0.0 112.019 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m 81.33 34.51 0.1 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.22 1.808 . . . . 0.0 112.919 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -115.04 155.26 27.34 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.582 2.353 . . . . 0.0 110.282 167.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -165.38 48.47 0.09 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.645 0.778 . . . . 0.0 111.94 -157.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -39.18 157.77 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 126.993 2.117 . . . . 0.0 116.44 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.73 105.64 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 O-C-N 120.095 -1.628 . . . . 0.0 114.125 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.61 -62.46 1.68 Allowed 'General case' 0 N--CA 1.48 1.052 0 O-C-N 120.634 -1.292 . . . . 0.0 111.966 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -129.8 135.52 27.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.075 1.75 . . . . 0.0 108.208 166.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.49 -37.24 19.5 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.163 3.242 . . . . 0.0 116.414 -163.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -62.43 -19.44 63.48 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.29 0.0 OUTLIER -137.48 108.74 6.83 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.475 1.489 . . . . 0.0 113.956 174.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -90.49 135.14 33.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.302 2.241 . . . . 0.0 112.821 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -110.52 143.83 40.28 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.915 2.886 . . . . 0.0 112.558 -165.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.05 53.68 0.63 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.936 1.695 . . . . 0.0 113.983 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.255 1.393 0 C-N-CA 128.552 2.741 . . . . 0.0 109.895 165.092 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -122.06 169.26 11.02 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.448 1.499 . . . . 0.0 112.777 -161.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 t -81.26 115.75 20.8 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.682 1.193 . . . . 0.0 111.223 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -91.7 90.35 7.51 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 112.443 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -23.72 82.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 128.852 2.861 . . . . 0.0 115.597 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.69 -170.03 34.46 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 127.532 2.491 . . . . 0.0 110.596 -173.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -67.97 143.78 55.46 Favored 'General case' 0 CA--C 1.56 1.362 0 O-C-N 119.609 -2.112 . . . . 0.0 112.461 173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -98.95 -47.49 5.24 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.069 1.348 . . . . 0.0 112.709 172.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.08 80.19 0.03 OUTLIER Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.212 1.387 . . . . 0.0 112.115 -174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.82 144.72 45.67 Favored Glycine 0 CA--C 1.543 1.839 0 O-C-N 121.061 -1.258 . . . . 0.0 114.5 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.2 109.99 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.471 1.136 . . . . 0.0 110.911 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.72 -54.14 0.56 Allowed Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.391 0.996 . . . . 0.0 113.487 -168.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.07 59.25 1.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 O-C-N 120.889 -1.36 . . . . 0.0 110.763 168.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -84.26 60.85 6.21 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.092 1.757 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.27 -159.51 12.97 Favored Glycine 0 CA--C 1.547 2.069 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -170.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.03 87.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.669 3.579 . . . . 0.0 115.679 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -160.87 51.33 0.27 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.831 2.052 . . . . 0.0 111.488 168.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.64 127.46 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.832 1.653 . . . . 0.0 114.083 -166.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.8 p -81.63 -175.41 5.52 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.84 152.96 43.16 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.4 t -62.62 119.18 8.73 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.32 -48.81 0.23 Allowed Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.109 2.29 . . . . 0.0 110.138 -170.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m 88.45 34.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 143.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.4 p -98.16 93.17 6.1 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.662 2.385 . . . . 0.0 111.359 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.95 76.56 1.95 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.65 1.98 . . . . 0.0 111.662 -164.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.87 136.91 32.76 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.355 1.862 . . . . 0.0 115.082 -160.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.85 108.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.236 1.814 . . . . 0.0 114.722 -169.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.84 -65.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 122.373 1.082 . . . . 0.0 110.437 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -119.39 151.25 51.05 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 126.589 1.955 . . . . 0.0 110.045 161.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.82 -47.28 0.63 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 124.651 3.568 . . . . 0.0 116.524 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -84.63 14.66 4.41 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.4 101.19 3.85 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.507 1.923 . . . . 0.0 111.872 171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -99.07 127.16 44.96 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.96 1.304 . . . . 0.0 112.786 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -128.13 133.84 49.03 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.37 2.668 . . . . 0.0 112.184 -166.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.3 t -81.28 85.34 6.41 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.686 1.594 . . . . 0.0 113.703 -170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.906 2.082 . . . . 0.0 111.661 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -118.52 -24.35 6.82 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.263 1.825 . . . . 0.0 113.644 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -113.62 142.96 45.35 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 143.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.282 52.3 m80 81.16 61.04 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 127.003 2.121 . . . . 0.0 115.254 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.77 91.22 7.85 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.79 2.836 . . . . 0.0 113.981 -174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.05 144.59 35.29 Favored Glycine 0 CA--C 1.542 1.719 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -158.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 2.16 99.11 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 130.858 3.663 . . . . 0.0 118.444 169.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 p -45.84 -49.7 15.01 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 153.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.85 141.29 6.35 Favored Glycine 0 CA--C 1.548 2.135 0 C-N-CA 126.114 1.816 . . . . 0.0 112.75 -161.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 -158.31 9.56 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.213 1.387 . . . . 0.0 112.917 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.32 138.04 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 O-C-N 120.245 -1.738 . . . . 0.0 110.739 171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 -61.09 2.73 Favored Glycine 0 CA--C 1.546 2.025 0 O-C-N 120.118 -1.614 . . . . 0.0 113.222 -175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 m-30 -65.1 71.72 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.843 1.657 . . . . 0.0 113.65 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 t -69.1 72.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.598 1.559 . . . . 0.0 112.66 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.49 -170.35 14.0 Favored Glycine 0 CA--C 1.554 2.528 0 C-N-CA 126.165 1.84 . . . . 0.0 116.121 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -70.71 77.89 1.38 Allowed 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 124.258 3.305 . . . . 0.0 117.336 -170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.9 m -70.41 56.83 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.185 -2.197 . . . . 0.0 112.556 163.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.37 161.6 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 -138.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -76.97 -135.31 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 111.293 164.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.81 161.34 23.97 Favored 'General case' 0 CA--C 1.556 1.201 0 O-C-N 119.509 -1.994 . . . . 0.0 112.619 155.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -64.5 -174.97 0.14 Allowed 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.55 -42.05 1.39 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 125.825 1.679 . . . . 0.0 116.03 166.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.0 m 79.54 51.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -77.01 168.57 19.87 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.11 -1.619 . . . . 0.0 111.919 154.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.89 142.52 27.71 Favored 'General case' 0 CA--C 1.555 1.163 0 O-C-N 120.967 -1.083 . . . . 0.0 113.187 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -168.19 176.78 5.81 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -151.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.0 102.33 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 125.522 1.529 . . . . 0.0 112.986 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.16 -61.82 1.88 Allowed 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.688 -1.257 . . . . 0.0 109.982 163.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -115.38 160.56 33.9 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 126.361 1.864 . . . . 0.0 109.434 152.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.93 -30.65 78.53 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.469 2.112 . . . . 0.0 114.122 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -87.04 16.34 5.11 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.95 99.49 2.27 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 171.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -83.33 124.35 30.53 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.163 1.385 . . . . 0.0 110.735 154.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -108.24 -127.75 0.27 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -164.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -134.25 85.7 2.21 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.452 1.501 . . . . 0.0 112.727 -161.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.256 1.429 0 C-N-CA 124.777 1.231 . . . . 0.0 112.98 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.251 10.9 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.66 103.1 14.99 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 120.994 1.724 . . . . 0.0 112.432 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -58.99 82.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.951 1.7 . . . . 0.0 111.697 163.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -71.81 136.53 47.09 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 120.376 -1.453 . . . . 0.0 112.54 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 42.26 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -168.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.57 -171.24 26.78 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 127.352 2.406 . . . . 0.0 112.564 170.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -75.27 149.49 38.8 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 120.033 -1.863 . . . . 0.0 112.187 172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -94.36 -35.02 12.57 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.05 0.19 Allowed Glycine 0 CA--C 1.542 1.722 0 C-N-CA 126.285 1.898 . . . . 0.0 111.145 -168.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.71 179.97 24.43 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -160.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.4 mt -35.91 115.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 125.235 1.414 . . . . 0.0 112.278 174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.45 4.86 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 114.479 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.79 68.15 4.69 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 120.801 -1.411 . . . . 0.0 111.252 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -85.83 68.98 10.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.027 1.731 . . . . 0.0 111.423 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.0 -166.71 29.4 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -51.02 90.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.924 3.749 . . . . 0.0 115.459 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -164.99 56.32 0.12 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 128.095 2.558 . . . . 0.0 110.076 167.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 p -96.22 125.47 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.42 1.488 . . . . 0.0 114.553 -162.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -92.72 164.26 13.44 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.947 1.699 . . . . 0.0 114.532 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.15 147.23 52.76 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -66.52 153.85 41.89 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.65 -46.79 0.76 Allowed Glycine 0 CA--C 1.541 1.689 0 C-N-CA 127.123 2.297 . . . . 0.0 110.409 -160.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m 77.69 18.0 1.33 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.136 1.374 . . . . 0.0 114.138 162.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.3 p -90.8 142.8 27.39 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.442 2.297 . . . . 0.0 111.131 166.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.7 t -160.11 126.16 4.18 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -76.99 175.98 9.07 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.487 2.715 . . . . 0.0 114.065 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.9 p -121.83 120.16 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.782 2.033 . . . . 0.0 111.381 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.49 -95.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.023 0 O-C-N 120.668 -1.27 . . . . 0.0 109.846 170.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.97 152.73 77.28 Favored Pre-proline 0 CA--C 1.554 1.132 0 O-C-N 120.304 -1.497 . . . . 0.0 110.15 150.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -33.44 -50.82 0.48 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.642 3.561 . . . . 0.0 116.657 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.91 -1.44 43.46 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.51 97.55 6.22 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.317 -1.489 . . . . 0.0 111.432 169.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.2 t -94.5 112.79 24.56 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.006 0.923 . . . . 0.0 112.69 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -102.74 130.08 49.58 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.226 1.81 . . . . 0.0 113.716 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 t -66.4 69.0 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.22 2.208 . . . . 0.0 115.025 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 128.155 2.582 . . . . 0.0 110.308 170.355 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.852 -1.071 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -77.21 54.75 1.12 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 120.722 1.601 . . . . 0.0 113.632 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -112.52 98.85 7.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.196 1.798 . . . . 0.0 109.872 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -146.68 -57.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.906 1.282 . . . . 0.0 112.837 -173.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 117.07 13.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.334 1.054 . . . . 0.0 113.168 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -48.46 -79.18 0.07 OUTLIER Glycine 0 CA--C 1.546 1.98 0 C-N-CA 125.373 1.463 . . . . 0.0 116.752 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.7 115.41 22.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 121.037 -1.272 . . . . 0.0 112.614 -174.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.58 10.52 5.82 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 117.346 2.351 . . . . 0.0 117.346 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.72 -58.72 0.63 Allowed Glycine 0 CA--C 1.546 1.991 0 CA-C-N 120.675 1.58 . . . . 0.0 115.103 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 147.51 4.57 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.772 1.177 . . . . 0.0 113.625 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.287 0.0 OUTLIER -52.17 137.52 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 119.223 1.511 . . . . 0.0 113.914 -176.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.67 -56.26 0.47 Allowed Glycine 0 CA--C 1.54 1.623 0 C-N-CA 125.799 1.666 . . . . 0.0 110.11 -138.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -58.08 78.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.599 1.19 . . . . 0.0 110.289 152.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 m -168.83 -47.06 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.896 2.878 . . . . 0.0 110.031 -157.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.09 -152.72 10.6 Favored Glycine 0 CA--C 1.552 2.345 0 C-N-CA 124.543 1.068 . . . . 0.0 113.28 163.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.32 66.15 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.435 3.423 . . . . 0.0 117.029 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -161.44 77.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.089 2.156 . . . . 0.0 109.21 161.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.91 151.19 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.803 -163.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.19 169.94 5.1 Favored 'General case' 0 CA--C 1.56 1.335 0 O-C-N 121.176 -0.953 . . . . 0.0 113.558 173.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.86 137.29 32.46 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -153.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.9 p 13.14 86.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 128.935 2.894 . . . . 0.0 118.566 158.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.58 36.69 3.21 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 126.768 2.128 . . . . 0.0 113.888 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m 170.66 147.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 129.602 3.161 . . . . 0.0 108.013 -161.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.2 p -135.07 173.51 11.64 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.95 1.3 . . . . 0.0 112.74 166.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -89.9 94.49 9.83 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 120.08 -1.637 . . . . 0.0 110.578 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -98.06 137.37 36.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.267 2.227 . . . . 0.0 112.953 -171.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.49 130.24 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 O-C-N 119.761 -1.837 . . . . 0.0 114.896 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -91.86 -80.16 0.36 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.178 1.391 . . . . 0.0 109.997 160.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -96.94 153.66 38.5 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.913 1.285 . . . . 0.0 109.993 160.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -36.1 -53.67 0.94 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.973 3.782 . . . . 0.0 116.268 -175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.88 32.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.15 86.91 2.24 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.282 1.833 . . . . 0.0 110.663 170.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -86.31 120.06 27.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.232 1.413 . . . . 0.0 110.709 168.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -121.91 135.19 54.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.081 1.752 . . . . 0.0 113.488 -168.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.6 89.94 0.07 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 126.631 1.973 . . . . 0.0 114.325 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.252 1.228 0 C-N-CA 128.511 2.724 . . . . 0.0 112.685 -179.504 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.87 90.19 3.49 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.533 1.133 . . . . 0.0 110.521 174.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -56.56 2.39 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.522 0.729 . . . . 0.0 111.85 170.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -45.47 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.12 2.168 . . . . 0.0 114.569 177.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.81 -150.0 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -167.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.53 -137.95 3.34 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 124.826 1.203 . . . . 0.0 113.254 173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -59.44 137.47 57.99 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.3 t -85.19 -49.17 8.44 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.247 1.819 . . . . 0.0 112.049 167.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.99 101.33 0.19 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.595 2.045 . . . . 0.0 110.209 -168.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.5 172.98 25.6 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.553 -0.969 . . . . 0.0 115.058 -173.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.96 124.25 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 O-C-N 121.02 -1.283 . . . . 0.0 110.898 166.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.67 -53.67 4.72 Favored Glycine 0 CA--C 1.543 1.837 0 O-C-N 120.693 -1.254 . . . . 0.0 114.27 -174.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.53 67.2 0.74 Allowed 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.106 -1.232 . . . . 0.0 111.868 171.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.2 m -84.41 -2.47 57.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.621 1.969 . . . . 0.0 114.79 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.63 166.65 50.98 Favored Glycine 0 CA--C 1.552 2.369 0 O-C-N 120.932 -1.105 . . . . 0.0 114.563 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -59.17 71.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 124.429 3.419 . . . . 0.0 117.102 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.7 t -104.14 50.16 0.8 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.314 -1.491 . . . . 0.0 111.787 161.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.09 132.05 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -166.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.9 176.04 9.97 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 126.309 1.844 . . . . 0.0 114.843 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.23 133.15 36.73 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.3 p -23.02 105.21 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 129.92 3.288 . . . . 0.0 118.911 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.0 67.55 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.837 1.684 . . . . 0.0 110.422 167.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.409 HG23 ' SG ' ' A' ' 35' ' ' CYS . 58.0 m -138.15 137.13 37.36 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -138.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 t -125.82 99.61 6.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.159 1.457 . . . . 0.0 112.687 165.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -74.38 107.17 6.37 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 127.449 2.299 . . . . 0.0 111.852 -173.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.04 -152.23 0.48 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -155.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.71 109.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 O-C-N 119.878 -1.764 . . . . 0.0 112.562 176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.91 -58.85 2.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.434 1.094 . . . . 0.0 110.471 173.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.74 151.82 52.68 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.499 1.519 . . . . 0.0 108.982 155.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -44.8 -38.22 12.65 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.908 3.072 . . . . 0.0 115.11 -176.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -82.16 10.53 6.62 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.88 83.12 0.8 Allowed 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.738 -1.226 . . . . 0.0 111.771 -176.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -70.84 123.29 21.62 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.437 1.495 . . . . 0.0 113.597 166.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -94.0 153.73 18.03 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.461 1.905 . . . . 0.0 113.817 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 23' ' ' THR . 50.7 t -93.72 105.34 17.38 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.891 1.277 . . . . 0.0 113.666 170.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.663 1.585 . . . . 0.0 112.704 164.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 117.93 -1.033 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -132.6 62.19 1.65 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.75 1.62 . . . . 0.0 110.099 166.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -95.79 124.74 39.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.624 1.569 . . . . 0.0 111.332 -177.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -71.14 164.35 25.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.082 1.353 . . . . 0.0 114.264 -174.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.7 67.63 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.867 1.667 . . . . 0.0 115.188 -173.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.31 143.79 16.25 Favored Glycine 0 CA--C 1.544 1.849 0 C-N-CA 126.717 2.103 . . . . 0.0 114.636 -176.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.09 118.29 7.68 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.885 1.674 . . . . 0.0 112.368 173.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.4 p -65.72 -21.0 66.49 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 174.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.42 -91.2 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 C-N-CA 125.039 1.304 . . . . 0.0 113.221 163.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 126.88 2.43 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.959 1.743 . . . . 0.0 110.961 178.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 132.5 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 119.114 1.457 . . . . 0.0 113.346 -170.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.87 -55.53 0.54 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -132.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -50.82 80.89 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.896 0.879 . . . . 0.0 111.098 144.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 m -167.15 -50.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.193 2.197 . . . . 0.0 111.04 -159.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.77 -159.23 9.46 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 123.551 0.596 . . . . 0.0 113.275 163.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -58.51 72.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.555 1.553 0 C-N-CA 124.597 3.532 . . . . 0.0 116.873 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 73.5 0.9 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.349 1.86 . . . . 0.0 110.986 166.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -92.24 130.91 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 125.6 1.56 . . . . 0.0 113.815 -169.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.02 -24.36 19.23 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.38 1.872 . . . . 0.0 115.303 -173.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.57 -77.16 0.26 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -155.0 -78.32 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -171.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.01 75.42 0.01 OUTLIER Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.696 1.839 . . . . 0.0 117.696 -153.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.289 11.6 t 58.16 -52.97 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.544 2.738 . . . . 0.0 115.468 -168.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -139.82 161.45 37.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.682 2.393 . . . . 0.0 111.452 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 t -55.15 141.46 34.79 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 120.457 -1.402 . . . . 0.0 112.111 166.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -69.84 171.82 8.66 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.242 1.417 . . . . 0.0 113.243 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 119.62 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-N 120.317 1.417 . . . . 0.0 113.332 172.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.48 -65.56 0.97 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.768 1.627 . . . . 0.0 112.85 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -90.89 -146.33 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.755 1.222 . . . . 0.0 108.963 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.81 -72.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 CA-C-N 121.03 1.404 . . . . 0.0 108.535 146.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.18 48.7 0.52 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.1 100.54 3.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.873 1.269 . . . . 0.0 110.348 166.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 t -105.55 122.04 45.2 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.319 1.447 . . . . 0.0 112.93 174.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -116.47 138.58 51.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -160.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.22 92.1 8.67 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 128.187 2.595 . . . . 0.0 114.782 -167.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.874 2.469 . . . . 0.0 115.497 -174.169 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -74.18 175.16 7.8 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 118.648 0.658 . . . . 0.0 110.335 152.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -149.11 51.21 0.97 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.428 1.091 . . . . 0.0 112.91 173.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.39 103.17 12.55 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.19 0.996 . . . . 0.0 110.861 172.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.15 161.2 30.87 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.61 -82.41 1.42 Allowed Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.958 -1.089 . . . . 0.0 113.16 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -79.3 148.39 32.14 Favored 'General case' 0 CA--C 1.556 1.202 0 O-C-N 120.987 -1.302 . . . . 0.0 113.993 -177.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -95.31 -56.73 2.62 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 121.169 -0.957 . . . . 0.0 111.771 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.72 90.46 0.08 OUTLIER Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.292 1.425 . . . . 0.0 112.338 -176.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.33 159.5 53.87 Favored Glycine 0 CA--C 1.544 1.895 0 O-C-N 121.236 -1.155 . . . . 0.0 115.694 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.05 132.72 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 O-C-N 121.068 -1.254 . . . . 0.0 110.545 166.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.83 -53.64 4.87 Favored Glycine 0 CA--C 1.543 1.781 0 O-C-N 120.71 -1.244 . . . . 0.0 113.354 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 55.55 0.45 Allowed 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.02 -1.282 . . . . 0.0 111.896 168.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -84.27 51.96 2.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.086 1.755 . . . . 0.0 112.654 -176.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.51 140.0 11.39 Favored Glycine 0 CA--C 1.545 1.939 0 C-N-CA 126.907 2.194 . . . . 0.0 110.952 177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.2 64.39 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 124.27 3.313 . . . . 0.0 117.521 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 t -82.28 40.78 0.65 Allowed 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.917 -1.74 . . . . 0.0 112.829 174.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.23 151.51 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -151.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -84.03 -152.84 0.14 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 125.065 1.346 . . . . 0.0 114.43 -178.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.09 -163.31 0.97 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.07 1.748 . . . . 0.0 113.519 177.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -89.38 170.64 10.38 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.48 1.112 . . . . 0.0 113.51 170.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.58 52.19 4.56 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.962 1.268 . . . . 0.0 111.845 -168.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -145.18 133.02 21.15 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 124.594 1.158 . . . . 0.0 110.421 -156.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . 0.261 22.4 p -116.4 1.16 12.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.049 2.14 . . . . 0.0 115.67 176.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t 63.24 57.86 1.5 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.251 1.82 . . . . 0.0 113.092 161.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -75.28 135.84 40.92 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 127.492 2.317 . . . . 0.0 116.294 -163.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.61 103.35 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 126.382 1.873 . . . . 0.0 114.592 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.07 -48.56 17.48 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.507 -1.371 . . . . 0.0 112.164 171.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -141.98 153.28 63.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 126.404 1.882 . . . . 0.0 109.015 161.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -49.88 -34.31 36.39 Favored 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 123.186 2.59 . . . . 0.0 115.521 -169.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -80.74 1.71 29.16 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.78 82.57 1.57 Allowed 'General case' 0 CA--C 1.559 1.297 0 O-C-N 120.688 -1.258 . . . . 0.0 112.893 -177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.9 t -81.83 136.51 35.37 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 121.36 -0.838 . . . . 0.0 112.947 169.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -127.15 147.77 50.18 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 127.714 2.406 . . . . 0.0 112.62 -161.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.6 t -68.23 61.46 0.08 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.632 1.573 . . . . 0.0 114.141 174.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.82 137.668 . . . . . . . . 0 0 . 1 stop_ save_